Gabapentin analogues for sleep disorders

Details Gabapentin analogues for sleep disorders Gabapentin analogues for sleep disorders

2006-11-28

2006-11-28

Kim, Vickie (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S561000, C514S572000, C514S530000, C562S503000

Reexamination Certificate

active

07141606

ABSTRACT:
The invention provides a new use of compounds for formula 1 or 1A or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of insomnia and related disorders.

REFERENCES:
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 4087544 (1978-05-01), Satzinger et al.
patent: 5084479 (1992-01-01), Woodruff
patent: 5510381 (1996-04-01), Pande
patent: 5929065 (1999-07-01), Lancel
patent: 6020370 (2000-02-01), Horwell et al.
patent: 6197819 (2001-03-01), Silverman et al.
patent: 6306910 (2001-10-01), Magnus et al.
patent: 6372792 (2002-04-01), Chouinard
patent: 6436974 (2002-08-01), Belliotti et al.
patent: 6689906 (2004-02-01), Bryans et al.
patent: 2002/0004528 (2002-01-01), Magnus et al.
patent: 2003/0004129 (2003-01-01), Bountra et al.
patent: WO97/33859 (1997-09-01), None
patent: 9921824 (1999-05-01), None
patent: WO99/21824 (1999-05-01), None
patent: 0002546 (2000-01-01), None
patent: WO00/02546 (2000-01-01), None
patent: 0142190 (2001-06-01), None
Rao et al., “Gabapentin-Augments Whole Blood Serotonin in Healthy Young Men”, J. Neural Transmission, 73:2, 1988, pp. 129-134; XP002132906.
Placidi et al., “[Poster session V: Clinical Efficacy; Pediatric Epilepsy; Genetics and Development][5.037]Effect of Chronic Treatment With Gabapentin on Nocturnal Sleep in Epilepsy”, American Epilepsy Society, Annual Meeting, abstract, 1997; XP-002132907.
Karam-Hage and Brower, “Gabapentin is Helpful for Insomnia in Alcohol-Dependent Patients During Early Recovery”, Alcoholism Clinical and Exp. Res., 23:5, 1999, abstract, p. 81A; XP-002132908.
Field et al., “Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents”, Brit. J. of Pharm., 121:8, 1997, pp. 1513-1522; XP-002043785.
Rodenbeck et al., “Alterations of the Sleep Stage Structure as a Feature for GABAergic Effects of a Valerian-Hop Preparation in Patients with Psychophysiological Insomnia”, Somnologie, 1998; 2, 26-31.

Affiliated with

Also associated with

Rating

Gabapentin analogues for sleep disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gabapentin analogues for sleep disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gabapentin analogues for sleep disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3703367